Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.63NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.263NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.135NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FK.1.4.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.13NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
DR.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.160.15NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.219NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
N.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.208NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.125.1 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.78 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.159NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.43.5 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XBC.1.6.4NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
FP.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.2.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.205NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.177NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.301NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.308NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.210NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.1.325NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.590NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.116NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.496NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
B.1.438.4NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
AY.49 (Delta)NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BF.38.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BF.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BT.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.2.55NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.76NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.1.30NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BE.11NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.5.2.9NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BF.31NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.4.6NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BF.24NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.3.1NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.3.13NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-18774.7Japan
BA.2.3.9NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.10.2NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.56NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.29NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.10NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.51NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.3.18NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
XATNNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
BA.2.24NNIID-JP-NTGGCAGCTGTGTAGGTCAAC20552928229263R-20522.3Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used